Population Pharmacokinetic Modeling of Blood-Brain Barrier Transport of Synthetic Adenosine A1 Receptor Agonists

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2004-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.104.071308PMID 15292459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a novel fluorescent microsphere technique to combine serial cerebral blood flow measurements with histology in the rat.

  2003influential reference
• Blood-brain barrier transport of synthetic adenosine A1 receptor agonists in vitro: structure transport relationships.

  2003influential reference
• Intracerebral microdialysis: 30 years as a tool for the neuroscientist

  2003cited by this paper
• Estimating impossible curves using NONMEM.

  2003cited by this paper
• Adenosine in the treatment of stroke: yes, maybe, or absolutely not?

  2001cited by this paper
• Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.

  2001cited by this paper
• Blood‐brain barrier transport and brain distribution of morphine‐6‐glucuronide in relation to the antinociceptive effect in rats – pharmacokinetic/pharmacodynamic modelling

  2001cited by this paper
• Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state.

  2000cited by this paper
• The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics.

  2000cited by this paper
• Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?

  1999cited by this paper
• Microdialysis for pharmacokinetic analysis of drug transport to the brain.

  1999cited by this paper
• Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?

  1999cited by this paper
• Adenosine receptor activation and nociception.

  1998cited by this paper
• Regulation of the movement of solutes across tight junctions.

  1998cited by this paper
• Effect of adenosine receptor modulation on pentylenetetrazole‐induced seizures in rats

  1997cited by this paper
• Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier.

  1997cited by this paper
• Application of Microdialysis in Pharmacokinetic Studies

  1997cited by this paper
• 8-Alkylamino-substituted analogs of N6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A1 receptors in vivo.

  1997cited by this paper
• Deoxyribose analogues of N6‐cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo

  1995cited by this paper
• Investigation of the Distribution of EAB 515 to Cortical ECF and CSF in Freely Moving Rats Utilizing Microdialysis

  1994cited by this paper
• Peptide drug delivery to the brain

  1993cited by this paper
• Quantitative microdialysis under transient conditions.

  1993cited by this paper
• Chapter 3 – Quantitative microdialysis

  1991cited by this paper
• A cell culture model of the blood-brain barrier

  1991cited by this paper
• Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro.

  1990cited by this paper
• Ionic Composition of Microdialysis Perfusing Solution Alters the Pharmacological Responsiveness and Basal Outflow of Striatal Dopamine

  1989influential reference
• Rationale for Monitoring Free Drug Levels

  1984cited by this paper
• First-Pass Elimination Basic Concepts and Clinical Consequences

  1984cited by this paper
• A new look at the statistical model identification

  1974cited by this paper

• Activation of adenosine receptor potentiates the anticonvulsant effect of phenytoin against amygdala kindled seizures.

  2015cites this paper
• Microdialysis in the Hepatobiliary System: Monitoring Drug Metabolism, Hepatobiliary Excretion, and Enterohepatic Circulation

  2011cites this paper
• Microfluidic Cell Culture and Its Application in High-Throughput Drug Screening

  2011cites this paper
• Recent advances in pharmacokinetic modeling

  2007cites this paper
• Chapter 6.4 Microdialysis as a method to study blood-brain barrier transport mechanisms

  2006cites this paper
• The role of blood-brain barrier studies in the pharmaceutical industry.

  2006cites this paper
• Pharmacokinetic/pharmacodynamic modelling of the anti-hyperalgesic and anti-nociceptive effect of adenosine A1 receptor partial agonists in neuropathic pain.

  2005cites this paper
• Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade

  2005cites this paper